Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term medical management and complications of 'resistant' ascites.

Literature DB >> 13918387

Long-term medical management and complications of 'resistant' ascites.

W H SUMMERSKILL, B F CLOWDUS, J W ROSEVEAR.

Abstract

This paper reports the experience of treating patients with hepatic cirrhosis and ascites with an aldosterone inhibitor in addition to conventional therapy. Good results are demonstrated in 13 patients previously resistant to treatment.

Entities: Disease Species

Keywords: ALDOSTERONE/antagonists; DIURETICS/therapy; LIVER CIRRHOSIS/therapy

Mesh：

Substances：

Year: 1961 PMID： 13918387 PMCID： PMC1413352 DOI： 10.1136/gut.2.4.285

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

34 in total

1. Cirrhosis of the liver: a study of alcoholic and nonalcoholic patients in Boston and London.

Authors: W H SUMMERSKILL; C S DAVIDSON; J H DIBLE; G K MALLORY; S SHERLOCK; M D TURNER; S J WOLFE
Journal: N Engl J Med Date: 1960-01-07 Impact factor: 91.245

2. The double portacaval shunt in the treatment of cirrhotic ascites.

Authors: W V MCDERMOTT
Journal: Surg Gynecol Obstet Date: 1960-04

3. Production of impending hepatic coma by chlorothiazide and its prevention by antibiotics.

Authors: J E Mackie; J M Stormont; R M Hollister; C S Davidson
Journal: N Engl J Med Date: 1958-12-11 Impact factor: 91.245

4. Kidney as a source of blood ammonia: effect of chlorothiazide.

Authors: E E OWEN; J F FLANAGAN; M P TYOR
Journal: Proc Soc Exp Biol Med Date: 1959 Oct-Dec

5. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).

Authors: S SHALDON; J R McLAREN; S SHERLOCK
Journal: Lancet Date: 1960-03-19 Impact factor: 79.321

6. Hyperaldo-steronism in liver disease. The treatment of refractory ascites by adrenalectomy and by the administration of spirolactones.

Authors: K S HENLEY; D H STREETEN; H M POLLARD
Journal: Gastroenterology Date: 1960-05 Impact factor: 22.682

2. Ascites and renal failure in liver disease: principles of management. Weekly clinical conference of the Section of Gastroenterology of the University of Michigan.

Authors: K S Henley
Journal: Am J Dig Dis Date: 1971-04

3. Factors that determine refractoriness of ascites to conventional therapy.

Authors: S Amra; R Elie; I Kronborg
Journal: CMAJ Date: 1986-09-01 Impact factor: 8.262

4. Resistant ascites in alcoholic liver cirrhosis: course and prognosis.

Authors: R R Capone; I Buhac; R C Kohberger; J A Balint
Journal: Am J Dig Dis Date: 1978-10

4 in total

Long-term medical management and complications of 'resistant' ascites.

1. Cirrhosis of the liver: a study of alcoholic and nonalcoholic patients in Boston and London.

2. The double portacaval shunt in the treatment of cirrhotic ascites.

3. Production of impending hepatic coma by chlorothiazide and its prevention by antibiotics.

4. Kidney as a source of blood ammonia: effect of chlorothiazide.

5. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).

6. Hyperaldo-steronism in liver disease. The treatment of refractory ascites by adrenalectomy and by the administration of spirolactones.

7. Effect of bilateral adrenalectomy in a patient with massive ascites and postnecrotic cirrhosis.

8. Paradoxical hyponatremia associated with congestive heart failure and with cirrhosis of the liver.

9. [Present status of delta-cortisone therapy of ascitic cirrhoses].

10. Portacaval anastomosis.

1. The aetiology and management of ascites in patients with hepatic cirrhosis: a review.

2. Ascites and renal failure in liver disease: principles of management. Weekly clinical conference of the Section of Gastroenterology of the University of Michigan.

3. Factors that determine refractoriness of ascites to conventional therapy.

4. Resistant ascites in alcoholic liver cirrhosis: course and prognosis.